Resources

Research showed type 2 diabetes patients who took once-weekly albiglutide attained significant reductions in A1C, comparable with those who were on once-daily liraglutide. "The data indicate that albiglutide is a reasonable alternative to other glucagon-like peptide-1 (GLP-1) receptor agonists for the treatment of diabetes. Researchers said that, "It has good …

When finalized, the World Health Organization guideline will provide countries with recommendations on limiting the consumption of sugars to reduce public health problems like obesity and tooth decay. For information on how to submit comments, see below…. 

Italian researchers report that polydeoxyribonucleotide (PDRN), an adenosine receptor A2A agonist, shows some efficacy in healing chronic diabetic foot ulcers….

In the largest study to date of the genetic basis of the disease, DNA data was brought together from more than 48,000 patients and 139,000 healthy controls from four different ethnic groups….

Playing Nintendo’s Wii Fit Plus led to improvements in many diabetic measurements…. 

At what age will people require more diabetic care?…

Children with different levels of islet autoantibodies studied… 

A review of recent studies suggests that some oral hypoglycemic agents may be safe and effective in pregnant patients…. Insulin is traditionally the treatment of choice in pregnant patients requiring medication to manage their blood glucose levels, as it is a hormone the body already produces naturally and should therefore …

Researchers discover that preoperative A1C is related to length of stay in the hospital following noncardiac surgeries…. 

Research shows that variations in SBP can negatively impact the development and progression of diabetic nephropathy in type 2 diabetes patients….